Top Story
February 18, 2019
Read the
Perspective
from
Monica Mukherjee, MD, MPH, FACC, FASE
Transgender women who received hormone therapy had an increased incidence of venous thromboembolic events and stroke compared with men and women not receiving hormone therapy, according to a study published in Circulation.
Martin den Heijer, MD, PhD, professor of internal medicine at Vrije University in Amsterdam, and colleagues analyzed data from 2,517 transgender women (median age, 30 years) and 1,358 transgender men (median age, 23 years) who were receiving hormone therapy. The hormone therapies included in this study were testosterone for transgender men and estrogen with or without antiandrogens in transgender women.
February 18, 2019
Among the top cardiology stories last week were an announcement by Regeneron Pharmaceuticals and Sanofi that they reduced the price of alirocumab by 60% and a study that…
In the Journals
February 18, 2019
Patients with ACS and acute decompensated HF who were discharged with an opioid medication were less likely to utilize planned health care, according to a study…
In the Journals
February 17, 2019
Implementing low-sodium salt substitutes in a diet can lead to a significant lowering of systolic and diastolic BP, according to a meta-analysis published in…